Geraldine Anastasio, PharmD
Geraldine Anastasio is Director, Regional Medical Research Specialist at Pfizer Global
Pharmaceuticals, where her responsibilities include research and medical information for
Pfizer’s Respiratory products including Chantix, Spiriva and Revatio. Upon earning her
Doctorate in Pharmacy from the Medical University of South Carolina, Dr. Anastasio
received an appointment as Assistant Professor in the School of Pharmacy at the
University of Arizona. She then moved on to Charlotte, North Carolina, where for 15
years she served as a clinical pharmacist faculty member in the Department Family
Practice, Carolinas Medical Center, where she conducted research, and trained medical
and pharmacy residents and students. Dr. Anastasio is a Fellow of the American College
of Clinical Pharmacy and has published numerous articles on pharmacotherapy. She is a
Board Certified Pharmacotherapy Specialist.
Michael C. Fiore, MD, MPH
Michael Fiore, professor of medicine at the University of Wisconsin, founded and has
served as Director of the University of Wisconsin Center for Tobacco Research and
Intervention (UW-CTRI) since it was established in 1992. He is clinically active, treating
patients both in internal medicine and for tobacco dependence.
Dr. Fiore is a nationally recognized expert on tobacco, providing perspectives to
audiences ranging from Good Morning America to the United States Senate. He has
written numerous articles, chapters, and books on cigarette smoking and was a co-author
and consulting editor of Reducing Tobacco Use—A Report of the Surgeon General
(2000).
Fiore served as chair of the panel that produced the United States Public Health Service
Clinical Practice Guideline: Treating Tobacco Use and Dependence, in 2000 which
provides a gold standard for healthcare providers. Currently, he serves as Co-Director of
a Robert Wood Johnson Foundation National Program Office, Addressing Tobacco in
Managed Care.
Dr. Fiore chaired the U.S. Department of Health and Human Services Subcommittee on
Tobacco Cessation of the Interagency Committee on Smoking and Health which
produced a comprehensive plan for promoting tobacco cessation in the United States. In
July 2003, he was one of five national recipients of the Innovators in Combating
Substance Abuse Award from the Robert Wood Johnson Foundation.
Fiore’s chief research and policy focus has been to develop strategies to prompt clinicians
and health care systems to intervene with patients who use tobacco. As part of this effort,
he spearheaded the concept of expanding the vital signs to include tobacco use status.
Recent research shows that 70 percent of physicians now ask patients about their
smoking status.
Dr. Fiore was Co-Principal Investigator for a five-year NIH-funded Transdisciplinary
Tobacco Use Research Center (TTURC) grant designed to understand tobacco
dependence in order to prevent relapse to smoking. In September, 2004, he began his role
as co-principal investigator of a second, TTURC grant, seeking to examine tobacco
dependence treatment and outcomes with an eye to determining the effectiveness of
various treatments and matching those treatments to smokers wishing to quit.
After graduating from Bowdoin College, Dr. Fiore completed medical school at
Northwestern University in Chicago and his internal medicine training at Boston City
Hospital. His postgraduate education included a Masters of Public Health from Harvard
University. Dr. Fiore received additional training as an Epidemic Intelligence Service
(EIS) Officer for the United States Centers for Disease Control where he also completed
a Preventive Medicine residency program at the United States Office on Smoking and
Health before coming to the University of Wisconsin-Madison.
Corinne G. Husten, MD, MPH
Corinne Husten received her MD degree from the Georgetown University School of
Medicine, and her MPH in epidemiology from Johns Hopkins School of Hygiene and
Public Health. She was initially Board Certified in Family Practice and subsequently in
Preventive Medicine. After practicing as a Family Practice physician in the private sector
for several years, she completed a Cancer Prevention Fellowship at the National Cancer
Institute. Dr. Husten then went to the Office on Smoking and Health, where she has
served for 12 years.
Dr. Husten currently serves as the Acting Director of the Office on Smoking and Health.
During her tenure as Acting Director, OSH has overseen the development of the National
Network of Cessation Quitlines, the implementation of a tobacco-free CDC campus, and
provided substantial technical assistance for the development of the Medicare cessation
counseling benefit. Prior to becoming the Director, Dr. Husten was Chief of the
Epidemiology Branch. As Branch Chief, she led surveillance, research, and evaluation
activities in the Office. In this capacity, she oversaw the initiation and development of
the Office evaluation activities, specific population surveys (American Indian/Alaska
Native, Hispanic, and LGBT), the state-based Youth and Adult Tobacco Surveys, the
Global Youth Tobacco Survey, expanded cessation activities, and product research in
OSH. Dr. Husten has more than 90 scientific publications on a variety of tobacco topics
including tobacco use in various populations, second hand smoke, minors’ access, the
tobacco farm subsidy program, cessation, and insurance coverage of tobacco use.
Dr. Husten’s major areas of individual research include treatment of tobacco use and
tobacco use among women. She was a chapter editor of the 2001 Surgeon General
Report on Women and Tobacco. She was also the CDC liaison to the Public Health
Service Smoking Cessation Guideline panel, a tobacco content expert to the Community
Preventive Services Task Force for the Guide to Community Preventive Services
recommendations, and a contributor to OSH’s “Best Practices” guideline. Dr. Husten is a
known expert on the science and practice of tobacco control and brings years of
management experience, scientific experience, and commitment to tobacco prevention
and control.
Donna Vallone, PhD
Donna Vallone joined Legacy in July 2003 to direct the Foundation’s research and
evaluation efforts, and help ensure scientific findings are accurately communicated
within the Foundation’s broad portfolio of counter-marketing.
Donna is a public health scientist with more than 10 years of experience in the areas of
applied research and program evaluation.
Donna joined Legacy from the Mailman School of Public Health at Columbia University
where she served as the Evaluation Director of the Center for Applied Public Health's
Downstate NY Healthy Start program.
Donna received her doctoral degree in Sociomedical Sciences, an interdisciplinary degree
between public health and sociology, from Columbia University, and her masters’ degree
in International Community Health Education from New York University.
Paul Vogelzang, MBA
Paul Vogelzang recently joined the Porter Novelli team and is already deeply involved
with a wide variety of new business activities as well as standing client work including
the Propane Education and Research Council and the Abundant Forests Alliance.
Bringing with him an interesting and varied background in marketing, Paul most recently
worked as the Special Assistant, E-Gov, in the office of the CIO with the United States
Department of Treasury. He has authored numerous articles on e-commerce, e-gov
issues, marketing of financial services, and specifically, their online availability and the
privacy issues surrounding those transactions. Additionally, Paul has appeared on
numerous network financial talk shows, among them, MSNBC, CNNfn, CNBC, NBC,
and is the producer of several top rated podcasts, including the first U.S. Treasury
podcast, and most notably, MommyCast, which was the 15th most widely listened to
show on Apple’s iTunes in 2005. Additionally, Paul was Chief Marketing Officer at
Tenet Healthcare and comes from a healthcare family: his father is a retired Internist; his
sister is an Internist is Seattle, WA, and his other sister is a MFCC in California.
Paul has a B.A. in Public Administration from the University of the Pacific and an
M.B.A. from LaSalle University, Graduate School of Business.